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Abstract 
Purpose: Previous studies have suggested 
that the hypopituitarism following 
traumatic brain injury (TBI) is more 
prevalent than traditionally thought. The 
objective of this study was to characterize 
longitudinal MRI morphometric changes of 
pituitary gland in patients with severe TBI.  
Materials and methods: Fourteen patients 
who had suffered a severe TBI (Glasgow 
Coma Score=3 - 8) underwent MRI at 
three time points: Time 1 (mean=31. 5 
days), Time 2 (98. 0) and Time 3 (185. 5). 
The pituitary gland volume was quantified 
by manually tracing on T1-weighted 
magnetic resonance images. Data from TBI 
patients were compared to 14 age- and sex-
matched uninjured controls. The 
relationships between pituitary volumetric 
measures and patient demographics, length 
of respiratory support and coma, and 
presence of intracranial hemorrhage or 
skull fractures were also analyzed.  
Results: Following TBI, the pituitary 
volumes were significantly greater at all 
three time points: Time 1: 
median=665mm3, range=460-830mm3, 
p=0. 007; Time 2: 694mm3, 467-866mm3, 
0. 007; and Time 3: 655mm3, 444-
795mm3, 0. 015, compared with controls 
(504mm3, 433-591mm3). At Time 1, 
pituitary volume was increased in 10 out of 
14 patients. Of these, early pituitary 
enlargements persisted up to six months in 
nine patients. Pituitary enlargements were 
negatively correlated with GCS, but not 
with other variables.  
Conclusion: Following a severe TBI, early 
pituitary enlargement found in most of our 
patients persisted in the chronic phases. 
Our data suggest a potential role of MRI 
morphometry in early prediction of 
pituitary dysfunction following head 
trauma, but further studies including 
hormonal measurements are necessary for 
validation.  
Key words: neuroimaging, traumatic 
brain injury, hypopituitarism  
Introduction 
Traumatic brain injury (TBI) represents 
a major cause of mortality and long-term 
morbidity. In the United States alone, each 
year approximately 1. 4 million people 
sustain a TBI(17) with an estimated cost of 
$60 billion. (10) At present, there are at 
least 5. 3 million TBI survivors, about 2% 
of the U. S. population, with long-term 








Although pituitary damage following 
TBI was reported as early as 1918,(7) 
interest in this clinical entity has grown 
with recent studies consistently reporting a 
high-risk of hypopituitarism, determined 
by endocrine testing, with an incidence of 
30-70% following TBI. (1-3, 5, 12, 18, 28) 
Despite this incidence, pituitary function 
testing has not become routine for patient 
management after TBI. Since the pituitary 
gland has the role of “endocrine brain”, we 
could speculate that the failure to diagnose 
post head trauma hypopituitarism (PHTH) 
might contribute considerably to morbidity 
and mortality in TBI patients. 
Consequently, the signs and symptoms of 
PHTH might be overlooked and could be 
interpreted as being post-TBI 
cognitive/behavioral sequelae. For example, 
clinical complaints such as headache, 
irritability, poor concentration and 
memory, depression, fatigue, decrease in 
libido, although considered symptoms of 
postconcussional syndrome, can also result 
from hypopituitarism, particularly of 
growth hormone (GH) deficiency. (9, 19, 
21, 24) Hormonal substitution therapies are 
used successfully for non-traumatic 
hypopituitarism and it has been suggested 
that TBI-mediated hypopituitarism might 
also benefit from appropriate hormonal 
supplements. (9, 21) 
Numerous attempts have been made to 
define criteria or to identify high-risk 
factors that indicate the need for endocrine 
testing post head trauma,(1, 3, 4, 13, 14, 18, 
24, 26, 28, 30, 31) but no valid prognostic 
index has been found to be sufficiently 
accurate. Since imaging investigations (CT, 
MRI) are mandatory in the management of 
most TBI patients, the identification of a 
quantitative neuroimaging biomarker of 
PHTH might be a reliable and cost-
effective tool to determine which TBI 
patients require endocrine testing and 
follow-up.  
The major goal of the present study was 
to quantify pituitary volume changes in the 
first six months after TBI. The relationship 
between pituitary volume changes, 
measured from MRI, and clinical factors of 
TBI severity (e. g. , skull fractures, length of 
coma) was also studied. We focused on 
severe TBI, since this group has a high-risk 
for developing PHTH, and on the first six 
months post-TBI when pituitary hormonal 
alterations are dynamic. (11, 15, 23, 30, 31)  
Materials and Methods 
Participants   
Fourteen TBI patients (4 women; age 
median=23yrs, range=16-47yrs) 
participated. Inclusion criteria were: severe 
TBI (Glasgow Coma Score, GCS<8); age: 
18-55 years; and body mass index: 17-30 
kg/m2 (see Table 1). Exclusion criteria 
were: previous and/or penetrating TBI; pre-
existing neurological and/or 
endocrinological disease; systemic 
conditions, such as chronic metabolic 
disturbance, hepatic failure, uremia, kidney 
transplant, uncontrolled diabetes; major 
substance abuse; and treatment with 
neuroleptic or antiepileptic drugs prior to 
the event. The severity of TBI was based on 
GCS assessment at 24 hours post-TBI(32) 
to minimize the possible effect of 
confounding factors that could overestimate 
the severity of trauma at emergency room 
(i.e., illicit drugs, sedation, alcohol). 
Histories for each patient, including the 
injury type, estimated severity and patient 
condition at presentation (from family 
interviews, medical chart reviews, 
emergency room notes, police reports) 








functions, history of resuscitation, degree of 
skeletal and visceral injury, cranio-cerebral 
lesions (skull fractures, posttraumatic 
intracranial hemorrhage/hematoma), 
anesthesia, respiratory support, and coma 
days were also recorded.  
Fourteen age- and sex-matched 
uninjured controls (4 women; 24. 5yrs, 18-
47yrs) without history of neurological and 
endocrinological disorder or drugs/alcohol 
abuse were recruited.  
All participants were informed of the 
experimental procedures and gave their 
written consent to this study that was 
approved by the local Institutional Review 
Board.  
MRI assessment and analysis  
Magnetic resonance imaging was carried 
out using a 3 Tesla Siemens Allegra scanner 
(Siemens Medical Solutions, Erlangan, 
Germany). We studied TBI patients at one 
month, when they were clinically stable for 
transport to our outpatient imaging facility 
(Time 1: actual mean=31. 5 days), three 
(Time 2=98. 0 days) and six months (Time 
3=185. 5 days) post-injury. A 3D axial T1-
weighted series (magnetization-prepared 
rapid gradient echo - MPRAGE, 
TR=1520ms, TE=4. 38ms, TI=900ms, 
flip angle=8 degree, 256x156mm2 matrix, 
1. 5mm slice thickness) was collected. We 
paid careful attention to patient positioning 
at each time point by using the reference 
landmarks as described previously. (6)  
Anterior and posterior pituitary gland 
was outlined manually on the T1-weighted 
images and the volume quantified by 
multiplying the traced area in each slice by 
the slice thickness and summing over all 
slices (MedInria v2. 0. Software, INRIA, 
Sofia Antipolis, France). The pituitary 
boundaries were drawn on the axial slices 
(Figure 1A and B), with confirmation on 
the simultaneously displayed sagittal and 
coronal planes (3D reconstruction, Figure 
1C and D), by a neurosurgeon. MRI data 
were analyzed blinded to group and time 
point. 
Accuracy and Reproducibility of Pituitary 
Volume Measurements 
To verify the anatomical accuracy of 
tracing, one investigator traced the pituitary 
boundaries on six randomly selected image 
sets. Then, a second investigator compared 
the tracings with an anatomic atlas (22). In 
the case of inaccuracy the tracing was re-
executed. This cycle was repeated until 
agreement was reached.  
To determine intra-rater reliability, 10 
pituitary image sets were traced by one 
investigator on two different occasions 
separated by 7-10 days. The second tracing 
was executed without reference to the first. 
 
  
Figure 1 Measurement of pituitary gland volume. 
(A) Outline of pituitary gland shown on complete 
axial T1-weighted slice (TR=1520ms, TE=4.38ms, 
TI=900ms, flip angle=8 degree).  (B) Magnified 
view of A showing detailed anatomy. (C) and (D) 
Corresponding sagittal and coronal views that are 
viewed simultaneously while tracing to ensure 
accurate boundaries 
The intra-rater reproducibility was 
extremely high (Spearman coefficient r=1. 








To determine inter-rater reliability, one 
investigator traced the pituitary boundaries 
on eight randomly selected image sets. A 
third investigator then traced these pituitary 
image sets without reference to the results 
of the previous investigator. The reliability 
between these independent raters was high 
(Spearman r=0. 81; p<0. 02).  
Statistical analysis 
Since the sample size was small, we used 
nonparametric methods obviating the need 
for assumptions of normal distributions in 
pituitary volume measurements. Analysis 
focused on one outcome measure (pituitary 
volume) and five variables (GCS at 24 
hours; number of days on ventilator 
support; number of days of coma; 
intracranial hemorrhagic lesions, where 
1=present and 0=absent; and skull 
fractures, where 1=present and 0=absent).  
The between-group comparisons at each 
time point were conducted by the Wilcoxon 
rank-sum/Mann-Whitney U test whereas 
the within group (TBI) comparisons were 
conducted by the Wilcoxon signed-rank 
test.  
To address the question of whether 
presence of overt injury was associated with 
pituitary volumes, we divided the TBI 
group based on the presence of either 
hemorrhage or skull fracture. We then used 
the Wilcoxon Rank-sum test to determine 
whether pituitary volumes were different 
for any subgroup at any time point.  
The relationships between pituitary 
volumes and clinical injury severity 
variables were estimated by the Spearman’s 
correlation coefficients between the 
pituitary volume at each time point and 
each of the five variables.  
Finally, we divided the TBI group 
according to their pituitary volume at Time 
1. We considered any pituitary volume that 
fell within the normal range of our healthy 
group mean to be normal and volumes that 
fell outside this range as abnormal. We then 
repeated the aforementioned analyses for 
the abnormal and normal TBI subgroups 
separately.  
All hypothesis testing was 2-sided and 
we did not attempt to control the 
experiment-wise Type I error rate. The 
significance level was set at α = 0. 05.  
Results  
Patient characteristics   
The causes of injury included motor 
vehicle accident (n=10), fall (2), and assault 
(2) (see Table 1), resulting in a severe TBI 
(GCS at 24 hours ranged from three to 
seven; seven patients had a GCS of three) 
with length of coma ranging between two 
and eight days (median=3. 5 days). All 
patients received oro-tracheal intubation 
and ventilator support (median=5. 5 days, 
range=2–19 days). Associated intracranial 
hemorrhagic lesions were present in 71% 
(10/14) of patients and fractures of skull 
vault in 43% (6/14). No patient had a skull 
base fracture. Half of the patients (n=7) 
presented with multiple trauma, including 
hemo- and/or pneumothorax (six patients), 
fractures (vertebral, pelvis, extremities), 
spleen laceration, and kidney contusion.  
Pituitary volume measurements 
The pituitary volume measurements 
were summarized by medians and ranges 
for each group and each time point (Table 
2). Compared with uninjured controls, the 
pituitary volumes in TBI survivors were 
significantly greater at all time points (see 




























1 41/M 23.6 MVA 3   5 6 
2 16/M 23.3 MVA 3 + + 6 11 
3 47/M 21.5 Assault 3 + + 8 10 
4 24/M 22.8 Fall 3 +  2 4 
5 20/F 19.9 MVA 3   3 3 
6 21/F 25.0 MVA 3 +  7 15 
7 18/M 21.5 MVA 3 + + 3 5 
8 27/F 28.8 MVA 5 + + 1 2 
9 24/M 22.2 MVA 6   3 14 
10 22/M 19.2 MVA 6 + + 5 5 
11 21/M 23.0 MVA 6 +  3 7 
12 47/F 22.0 Assault 6  + 2 2 
13 26/M 25.4 MVA 7 +  6 19 
14 22/M 22.1 Fall 7 +  4 4 
Note. BMI = Body Mass Index; F = female; GCS = Glasgow Coma Score; M = male; MVA = motor vehicle 
accident; + = present.  Patients are ranked according to Glasgow Coma Score. 
 
Overall, these values suggest that 
following TBI, pituitary volumes are higher 
than normal (uninjured control vs. Time 1; 
p=0. 007), followed by further enlargement 
up to three months (Time 2 vs. 1; p=0. 09) 
and finally apparent return toward normal 
range at six months post TBI (Time 3 vs. 2; 
p=0. 02; Table 2 and Figure 2).  
At Time 1, 10 of the TBI patients (71%; 
TBI patients # 3-7 and 9-13 in the Table 2) 
had pituitary volumes outside the normal 
range of the uninjured group. In this TBI 
subgroup (abnormal TBI subgroup), the 
median pituitary volume increased slightly 
from 718 to 753mm3 at Time 2 (Time 2 vs. 
1, p=0. 06) and decreased to 673mm3 at 
Time 3 (Time 3 vs. 2 and 1, p=0. 01 and 0. 
16 respectively). Although the pituitary 
volumes decreased between Times 2 and 3, 
the volumes measured at Time 3, 
nonetheless, remained above the uninjured 









Pituitary volumes (mm3) in TBI survivors 
and healthy controls 
Subject TBI patients Uninjured 
controls 
 Time 1 Time 2 Time 3  
1 499 513 507 433 
2 460 481 486 501 
3 739 866 659 499 
4 711 760 743 571 
5 830 811 795 504 
6 794 781 740 548 
7 761 820 659 529 
8 584 528 504 494 
9 725 706 550 456 
10 645 654 617 492 
11 662 683 651 512 
12 668 747 688 504 
13 615 666 693 576 
14 470 467 444 591 
Median 665‡ 694‡ 655† 504 
Range 460 - 830 467 - 866 444 - 795 456 - 591 
Mean±SD 654 ± 118 677 ± 133 624 ± 109 521 ± 45 
Note. † p < 0.05; ‡ p < 0.01 compared with uninjured 
controls.  Patients 1, 2, 8, and 14 remained within the 
normal range throughout the study period. 
 
The four patients (# 1, 2, 8, and 14) 
with pituitary volumes within the normal 
range at Time 1 (normal TBI subgroup) did 
not show significant progression over time 
(median=465, 497, and 485mm3 at Times 
1, 2, and 3, respectively). 
 
 
Figure 2 Median and range pituitary volumes (mm3) in 
uninjured (open square) and TBI (filled square) groups. 
In the TBI group, pituitary volumes were measured at 
three time points: Time 1 (one month-post TBI), Time 
2 (three months) and Time 3 (six months). Asterisks (*) 
indicate significant differences between TBI and healthy 
groups, and carat (^) between Time 3 and Time 2 in 
TBI group  (p < 0.05). 
Correlations between pituitary volume 
measurements and clinical variables 
Although, for the entire TBI group, the 
pituitary volume at all time points was 
negatively correlated with the GCS, none of 
these correlations was significant (p=0. 16, 
0. 10, and 0. 33 at Times 1, 2, and 3 
respectively). However, for the abnormal 
TBI subgroup, we found stronger 
correlations at all time points (Time 1: r=-
0. 84, p=0. 002; Time 2: r=-0. 87, p=0. 
001; Time 3: r=-0. 46, p=0. 18; see Figure 
3).  
For both the whole TBI group and the 
abnormal subgroup, correlations between 
pituitary volume and number of coma days 
or ventilator support days did not reach 
statistical significance at any time point. No 
significant difference was found between 
the patients with and those without 










We found substantially larger pituitary 
volumes in the majority of survivors of 
severe TBI compared with uninjured 
controls. We interpret the larger volumes as 
indicating injury-related enlargement. 
Moreover, in these patients, the pituitary 
volume tended to increase until three 
months. Although there was some 
indication of recovery by six months post-
injury, pituitary volume in all but one 
patient remained above the normal range. 
In contrast, none of the patients with 
pituitary volumes in the normal range at 
one month post-injury presented with 
pituitary enlargement over the same period.  
Our findings are consistent with recent 
reports of pituitary enlargement in the acute 
(0-7 days) phase of moderate to severe 
TBI(20). However, an association between 
increased pituitary volume and pituitary 
dysfunction following TBI is still to be 
elucidated. The hypothalamus-pituitary axis 
can be directly or indirectly altered by TBI. 
Hypoxia, edema, intracranial hemorrhage 
or increased intracranial pressure,(8) 
subsequent to trauma of either pituitary, 
hypothalamus, stalk, or other brain regions 
are potential mechanisms underlying such 
dysfunction. Histological studies of TBI-
induced alterations of this axis have found 
various degrees of pituitary hemorrhage, 
ischemic necrosis, fibrosis and/or 
thrombosis. (1, 24-26) However, the most 
prevalent mechanisms associated with 
pituitary dysfunction seem to be 
hemorrhage and ischemia. (13) To date, no 
correlations between the type or extent of 
histological pituitary alterations and 
characteristics of trauma, such as 
mechanism, extension and type of brain 
injuries, or skull fractures, have been 
reported,(24) although one study found no 
histological changes in 14 to 74% of TBI 
cases. (26) In addition, pituitary dysfunction 
might be secondary to other TBI-related 
factors, such as cardiac arrest and 
medications used post-TBI (e. g. , 
etomidate, heparin, anticonvulsants, 
benzodiazepines). (8, 24) Furthermore, an 
autoimmune process involving 
hypothalamic-pituitary region triggered by 
head trauma might play a role in the 
development of pituitary dysfunction post 
TBI. (29)  
The trend toward normalization of 
pituitary volume at six months post-TBI 
was also suggested at 12 months follow-up. 
(20) Recently, an integrative 
neuroimaging/hormonal study of chronic 
(17±15 yrs) TBI patients reported pituitary 
gland volume changes in 80% of patients 
with hypopituitarism, and in only 29% 
without,(27) with loss of volume or empty 
sella the most common abnormality seen. 
Taken with those of other studies, (20, 30) 
our data raise the question of whether the 
reductions of pituitary volumes seen in the 
chronic phases of TBI represent true 
recovery or whether it is a step toward 
further deterioration (i. e. , atrophy) as 
suggested by Schneider et al. (27) Further 
studies over an extended period might 
answer this question. Nevertheless, over a 
period of 3 years post-TBI,(31) a recovery 
of pituitary function was reported in most 
patients with worsening or new onset of 
hypopituitarism rarely occurring.  
In our patients, the pituitary volume was 
correlated with TBI severity i. e., low GCS 
at 24 hours predicted larger volume (see 
Figure 3). Although our result is consistent 
with previous findings that GCS at the 
emergency room predicts the development 
of PHTH, (12) other studies reported no 
association between GCS and the 









Figure 3 Correlations between pituitary volumes at 
one (Time 1), three (Time 2) and six (Time 3) 
months post-TBI and Glasgow Coma Score 24 
hours post-event in the TBI abnormal subgroup 
(n=10) that presented with significantly largely 
pituitary gland volume at Time 1 compared to the 
uninjured group. 
 
Several risk factors associated with injury 
severity have been identified in the context 
of PHTH. One of these is presence of skull 
base fracture. (28) However, none of our 
patients presented with skull base fracture. 
In contrast, some of our patients sustained 
fractures of the cranial vault. However, the 
presence of cranial vault fractures was not 
correlated with pituitary volume changes. 
Another risk factor for hypopituitarism is 
the presence of subarachnoid hemorrhage, 
(2, 5, 16) which might indicate the need for 
follow-up to detect delayed 
hypopituitarism. (19) However, we found 
no relationship between the presence of 
intracranial hemorrhagic lesions and 
pituitary enlargement. Finally, we found no 
significant correlation between pituitary 
enlargement and length of ventilator 
support at any time point.  
The present study has some limitations: 
(i) we focused on severe TBI patients who 
survived for six months after the event, 
which might contribute a selection bias i. e., 
the event was serious enough to induce a 
severe, but not terminal, TBI; (ii) we 
acquired the imaging data in the axial, 
rather than the commonly-used coronal, 
plane. However, we used the same 3D 
reconstruction to obtain reference coronal 
and sagittal images in survivors and 
uninjured controls and do not expect bias 
from this source; (iii) although the small 
sample size might limit the generalizability 
of our results, this approach may be used to 
determine post-traumatic morphometric 
pituitary changes. However, in the absence 
of hormonal determination, any attempt to 
suggest the presence of hypopituitarism 
remains speculative. Longitudinal 
endocrinological studies have shown that 
PHTH occurs mainly in the acute phase of 
TBI, but later appearance has been also 
described. Giordano et al. (11) reported that 
pituitary insufficiency at three months post-
TBI persisted at 12 months follow-up in 
patients with multiple hormonal 
dysfunctions, but recovered in those with 
only isolated hormonal dysfunction. 
Additionally, 5% of cases with initially 
normal pituitary function presented with 
subsequent pituitary insufficiency. This is 
further confirmed by the recently reported 
appearance of new PHTH cases at 12 and 
36 months post-TBI. (30), (31) In contrast, 
a prospective study (15) suggests that 
recovery of PHTH is the sole tendency in 
TBI patients at 12 months, with no new 
insufficiencies reported during that time 
period. Thus, the functional (hormonal) 
profile of the pituitary gland seems to be 
quite dynamic following TBI, and a 
combined, imaging and hormonal, 
approach might increase the understanding 
of the mechanisms underlying 
hypopituitarism following head trauma. 
Since the sub-acute stage (one month post) 
represents a potentially rich set of 
restorative therapy targets, these results 
would be especially useful for prospectively 








hypopituitarism. Our results might help 
clinical decision-making and determining 
individual treatment strategies.  
Summary Statement/Conclusions 
Larger pituitary volumes were found at 
one month after injury in the majority of 
survivors of severe TBI compared with 
uninjured controls, with elevated, or 
normal, pituitary volumes at three or six 
months predicted by the volumes observed 
at one month after injury.  
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